After suspending visiting earlier in the year, we are now able to offer limited visiting to some wards at the discretion of the nurse in-charge.”
Read more on visiting times...
We recognise the impact that a long stay in hospital can have on families and the importance of maintaining strong communication. Our ward staff are keeping in touch with patients’ next of kin directly and our Patient Advice and Liaison Service (PALS) can help pass on personal messages from family and friends.
After suspending visiting earlier in the year, we are now able to offer limited visiting to some wards at the discretion of the nurse in-charge.”
Read more on visiting times...
We recognise the impact that a long stay in hospital can have on families and the importance of maintaining strong communication. Our ward staff are keeping in touch with patients’ next of kin directly and our Patient Advice and Liaison Service (PALS) can help pass on personal messages from family and friends.
The Queen Alexandra Hospital is located just on the hill slopes of Portsdown Hill overlooking Portsmouth. It is conveniently situated for both the M27 and A3M.
Family members and carers play an important role in supporting patients during an episode of ill health. We are committed to the active involvement of family members, friends and carers during a hospital stay. Family members and carers play an important role in supporting patients during an episode of ill health.
More information on visiting hospital for an appointment.
If you've had experience of using our services and would like to make a comment then please contact the Patient Advice and Liaison Service (PALS). Your views are very important to us and we would like to hear where you think improvements are needed or where things have gone so well that you would like to share your thanks or gratitude with the staff involved. When things have not gone so well then you can be sure that we want to hear from you, so please get in touch with PALS.
During your stay in hospital you will meet a number of different members of staff. All members of staff wear name badges, but if you are not sure who someone is or what they do, please feel free to ask them to introduce themselves and explain what they do.
If you have any questions about your treatment, please ask a doctor or a nurse.
There are lots of opportunities for you to get involved with the Trust, from volunteering to attending our public meetings, our Annual General Meeting or our hospital open day which is held every year.
We welcome and value your feedback and use the views you share with us in a number of ways to learn and make improvements as well as sharing best practice. Feedback can be provided in a number of ways.
Date: 05 October 2021
Volunteers are needed for the latest COVID-19 vaccine booster study which has launched in Portsmouth.
Local residents will have the opportunity to take part in the study, which is running at the Portsmouth Research Hub, part of Portsmouth Hospitals University NHS Trust.
The study will explore whether a single booster injection developed by the pharmaceutical company Sanofi in partnership with GSK, safely creates a broad immune response against the different COVID-19 variants.
The study is open to adults aged 18-years-old and over who are fully vaccinated against COVID-19, having previously received two doses of an approved COVID-19 vaccine.
For the first phase of the study, researchers are specifically looking for volunteers aged 18 to 55 who have received two doses of the Oxford/AstraZeneca COVID-19 vaccine.
For the second phase of the study, which is expected to launch in November, researchers would like to hear from anyone over the age of 18 who has received two doses of either the Oxford/AstraZeneca or the Pfizer/BioNTech COVID-19 vaccines.
The study is open to healthy volunteers, as well as those with health problems which might put them at greater risk of complications from COVID-19. Across the UK, around six hundred volunteers will take part across five National Institute for Health Research-supported sites.
Anyone interested in taking part in the study can visit the study website ( www.sanofistudies.com/covidbooster/) to find out more and sign up.
Recruitment to the study has already begun in the United States, Australia and France, and will soon begin in Spain. The first group of UK volunteers for the study were vaccinated in September 2021.
Those involved in the study may contribute to the development of an additional vaccine that works for the good of global public health. Initial data from the study are expected to be available in quarter 4 of 2021.
Since the opening of the Portsmouth Research Hub at the John Pounds Centre in Portsea in March 2021, hundreds of Portsmouth residents have come forward to support COVID-19 vaccine research.
Residents have already taken part in the COV-Boost study, which is looking at different COVID-19 vaccines given as a third ‘booster’ dose, as well as a study exploring how well an Oxford/AstraZeneca variant vaccine protects against the Beta COVID-19 variant, first identified in South Africa.
Dr Patrick Moore, a GP and local investigator for the study, said:
“We have been overwhelmed by the response from the local community and would like to thank Portsmouth residents for their continued support and for stepping forward to take part in our vital COVID-19 vaccine research.
“It is important that we continue to test new COVID-19 vaccines as they become available and the results of this study will inform future vaccine booster programmes, helping us to understand how we can best protect the population.”
Professor Adam Finn, Chief Investigator for the study, said:
“Throughout the pandemic we have seen excellent engagement and participation from the public within multiple pivotal vaccine studies. By examining the safety and effectiveness of the booster vaccine from Sanofi, it’s hoped researchers and participants can help add another option to our current portfolio of vaccines.
“Booster vaccines from different suppliers will give us a broader range of vaccines and help us to reinforce supply as we look to boost immunity in the population going forward, as needed.”
Professor Andrew Ustianowski, National Clinical Lead for the UK NIHR COVID Vaccine Research Programme, said:
“In addition to the several other COVID-19 vaccine studies running across the UK, this latest booster study from Sanofi will help inform future vaccine plans across the UK and beyond.
“As more of the population become fully vaccinated, research and studies such as this continue to strengthen our understanding of how we can help protect everyone against coronavirus moving forward.”
https://www.sanofistudies.com/covidbooster/
